PIMS

FloQast Achieves ISO 27701 Certification

Retrieved on: 
Wednesday, November 15, 2023
Privacy, Certification, Organization, ISO, PIMS, Trust, Medical device, FloQast

FloQast's ISO 27701 certification was achieved after a successful audit by Coalfire Systems, Inc. , an accredited certification body.

Key Points: 
  • FloQast's ISO 27701 certification was achieved after a successful audit by Coalfire Systems, Inc. , an accredited certification body.
  • "We are proud to have achieved ISO 27701 certification," said Vicky Levay, Sr. Director, Compliance at FloQast.
  • FloQast's ISO 27701 certification is available to all customers on demand in the FloQast application, along with its other compliance reports.
  • FloQast will also provide its ISO 27701 certification to prospects upon request, contingent on a non-disclosure agreement.

eClinical Solutions Doubles Down on Data Security, Privacy with New ISO Certifications

Retrieved on: 
Tuesday, November 14, 2023
Professional Services, Health, Data Analytics, Technology, Health Technology, Software, Clinical Trials, Quality, Information, Information security management, Risk management, PIMS, Privacy, GDPR, Risk, ISO, International Organization for Standardization, ISMS, General Data Protection Regulation, Clinical data management, Posture, Security, SOC, Certification, Environment, Medical device, Audit

eClinical Solutions , a global provider of digital clinical software and services, today announced it has obtained ISO 27001:2022 and 27701:2019 certification of its Information Security Management (ISMS) and Privacy Information Management Systems (PIMS) from the International Standards Organization (ISO).

Key Points: 
  • eClinical Solutions , a global provider of digital clinical software and services, today announced it has obtained ISO 27001:2022 and 27701:2019 certification of its Information Security Management (ISMS) and Privacy Information Management Systems (PIMS) from the International Standards Organization (ISO).
  • The new accreditations, in addition to eClinical Solutions’ longstanding SOC 2 Type II compliance, highlight the company’s commitment to managing risk related to the security of data it owns and manages, keeping that data safe, and complying with evolving privacy laws and regulations.
  • “We remain focused on the continuous improvement of our cybersecurity and data privacy program to protect our clients’ and employees’ valuable data.
  • eClinical Solutions’ certifications were issued by ISOQAR, Inc, an accredited certification body against a variety of management standards, based on the successful completion of a thorough, formal audit.

New process definition capabilities in PIMS further enhance quality assurance and "right -first-time" initiatives for pharma manufacturers

Retrieved on: 
Tuesday, November 28, 2023
GxP, IDBS, SOP, CPV, PIMS, Cryptocurrency

WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.

Key Points: 
  • WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.
  • Process definition templates enable pharma manufacturers to template process steps and quality specifications for faster process definition set-up and improved harmonization across the manufacturing teams to further enhance quality assurance (QA) and "right-first-time" initiatives.
  • This release builds on recent PIMS' process definition enhancements that added process definition versioning and approvals to help alleviate manual standard operating procedure (SOP) requirements and enhance QA for a more robust GxP environment.
  • PIMS' customers report that these standardized process definition templates will reduce their manual process definition set-up and enable easy, harmonized site and product comparisons.

New process definition capabilities in PIMS further enhance quality assurance and "right -first-time" initiatives for pharma manufacturers

Retrieved on: 
Tuesday, November 28, 2023
GxP, IDBS, SOP, CPV, PIMS, Cryptocurrency

WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.

Key Points: 
  • WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.
  • Process definition templates enable pharma manufacturers to template process steps and quality specifications for faster process definition set-up and improved harmonization across the manufacturing teams to further enhance quality assurance (QA) and "right-first-time" initiatives.
  • This release builds on recent PIMS' process definition enhancements that added process definition versioning and approvals to help alleviate manual standard operating procedure (SOP) requirements and enhance QA for a more robust GxP environment.
  • PIMS' customers report that these standardized process definition templates will reduce their manual process definition set-up and enable easy, harmonized site and product comparisons.

IDEXX Laboratories Announces Third Quarter Results

Retrieved on: 
Wednesday, November 1, 2023
Health, Technology, Health Technology, Software, Pharmaceutical, Biotechnology, Veterinary, Idexx Laboratories, IDXX, Laboratory, LPD, CAG, Growth, PIMS, EPS, Google Images, Appetite, Pharmaceutical industry, Music, Security (finance), Medical imaging, Tourism

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.

Key Points: 
  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
  • "Strong execution by IDEXX teams and sustained interest in adopting IDEXX's differentiated multi-modality testing and workflow solutions helped deliver solid organic revenue gains and strong financial results in the third quarter," said Jay Mazelsky, President and Chief Executive Officer.
  • The Companion Animal Group generated revenue growth of 9% as reported and 8% organic for the quarter.
  • Additional U.S. companion animal practice key metrics are available in the Q3 2023 Earnings Snapshot accessible on the IDEXX website, www.idexx.com/investors .

GBank Financial Holdings Inc. Announces Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, October 31, 2023
ZOOM, Bank, USDA, Brick, Federal Reserve Bank, Federal, Q3, Interest, PIMS, COVID-19, Partnership, Current Expected Credit Losses, Insurance, Sale, Smartphone, Telephone, GAAP, CIMS, Federal Reserve Bank of St. Louis, Internet, Zoom, Marketing, Commercial, The Wall Street Journal, Sport, BCS, Federal Home Loan Banks, Fintech, Federal Reserve, Growth, The Company, Borrowing base, SBA, Patent, Card, BankCard Services, Federal funds, ASC, Government, ACL, ASU, PPP, Credit card, PST, Sports betting, Cryptocurrency, Security (finance), Drug, Video game, Payment card, Real estate, Mobile phone, Sightline (architecture)

For the quarter ended September 30, 2023, loan originations by the Bank's SBA and Commercial Lending divisions increased 19% to $81.1 million, compared to $68.0 million for the prior linked quarter.

Key Points: 
  • For the quarter ended September 30, 2023, loan originations by the Bank's SBA and Commercial Lending divisions increased 19% to $81.1 million, compared to $68.0 million for the prior linked quarter.
  • For the quarter ended September 30, 2023, the Company's equity to assets ratio was 12.97% and the Bank's Tier 1 leverage ratio was 16.18%.
  • For the quarter ended September 30, 2023, net interest income increased 10% to $9.5 million, compared to $8.7 million for the prior linked quarter.
  • For the quarter ending September 30, 2023, Gaming FinTech deposits averaged $31.6 million, compared to $45.7 million for the prior linked quarter.

Artera Achieves SOC 2 Type 2 Compliance for Data Security, Availability and Privacy

Retrieved on: 
Tuesday, October 31, 2023
ISMS, Software as a service, SOC, American Institute, AICPA, Trust service provider, HIPAA, Availability, PII, HITRUST, Face, Certification, Organization, Maintenance, PIMS, Trust, Risk, Health, Safety, General counsel, Patient, ISO, Miss Hall's School, Information, Medical device, Risk management, Privacy

SANTA BARBARA, Calif., Oct. 31, 2023 /PRNewswire/ -- Artera, a SaaS digital health leader in patient communications, has achieved Service Organization Control (SOC) 2 Type 2 compliance for the following Trust Services Criteria: Security, Availability and Privacy. The rigorous audit, issued by the American Institute of CPAs (AICPA), is designed to ensure cloud-based service providers store and process client data in a secure manner. The attainment of this voluntary third-party compliance report underscores Artera's dedication to delivering the highest level of data security and privacy for its 700+ healthcare providers and federal agency customers.

Key Points: 
  • The attainment of this voluntary third-party compliance report underscores Artera's dedication to delivering the highest level of data security and privacy for its 700+ healthcare providers and federal agency customers.
  • Artera Achieves SOC 2 Type 2 Compliance for Data Security, Availability and Privacy
    Data security is top of mind for healthcare providers today.
  • In addition to SOC 2 Type 2, Artera is certified with:
    HITRUST : As the gold standard for organizations in healthcare, Artera has been HITRUST-certified since 2019.
  • As the leader in patient communications, Artera has been championing data security and compliance for more than eight years.

Veterinary Diagnostic Market Worth $5.0 billion | MarketsandMarkets

Retrieved on: 
Thursday, October 26, 2023
Research, Dermatology, Pet, Health, Veterinary medicine, PIMS, Risk, Telehealth, Partnership, Thermo Fisher Scientific, Public, AI, Infection, Microfluidics, Veterinarian, Idexx Laboratories, Cat, Acquisition, Milk, University, American Pet Products Association, Dog, Patient, Randox, POC, FEC, Research and development, Animal, Fujifilm, Communication, UK Rapid Test Consortium, Laboratory, Parasitism, Livestock, Disease, Vaccination, Science, Personalized medicine, Pet industry, Medical device, Vaccine, Medical imaging

The veterinary diagnostics market is divided into companion animals and livestock in the animal type segment.

Key Points: 
  • The veterinary diagnostics market is divided into companion animals and livestock in the animal type segment.
  • Key Market Players of Veterinary Diagnostic Industry:
    The veterinary diagnostics market is a consolidated market with the presence of few dominant multinational market players.
  • Research and Development: Ongoing innovations in diagnostic technologies contribute to the advancement of veterinary medicine and drive further research in animal health.
  • Economic Benefits: Timely and accurate diagnostics can reduce healthcare costs and losses in livestock and agricultural settings, making the veterinary diagnostic market economically advantageous for various stakeholders.

Veterinary Diagnostic Market Worth $5.0 billion | MarketsandMarkets

Retrieved on: 
Thursday, October 26, 2023
Research, Dermatology, Pet, Health, Veterinary medicine, PIMS, Risk, Telehealth, Partnership, Thermo Fisher Scientific, Public, AI, Infection, Microfluidics, Veterinarian, Idexx Laboratories, Cat, Acquisition, Milk, University, American Pet Products Association, Dog, Patient, Randox, POC, FEC, Research and development, Animal, Fujifilm, Communication, UK Rapid Test Consortium, Laboratory, Parasitism, Livestock, Disease, Vaccination, Science, Personalized medicine, Pet industry, Medical device, Vaccine, Medical imaging

The veterinary diagnostics market is divided into companion animals and livestock in the animal type segment.

Key Points: 
  • The veterinary diagnostics market is divided into companion animals and livestock in the animal type segment.
  • Key Market Players of Veterinary Diagnostic Industry:
    The veterinary diagnostics market is a consolidated market with the presence of few dominant multinational market players.
  • Research and Development: Ongoing innovations in diagnostic technologies contribute to the advancement of veterinary medicine and drive further research in animal health.
  • Economic Benefits: Timely and accurate diagnostics can reduce healthcare costs and losses in livestock and agricultural settings, making the veterinary diagnostic market economically advantageous for various stakeholders.

MWI Animal Health Completes Integration with Shepherd Veterinary Software

Retrieved on: 
Monday, October 16, 2023
Veterinary, Technology, Telecommunications, Software, Practice Management, Health, Pharmaceutical, General Health, Data Management, MWI, Partnership, Senior, Shepherd, Patient portal, PIMS, United States Commercial Service, AmerisourceBergen, Customer engagement, Veterinary medicine, Growth

MWI Animal Health, a provider of state-of-the-art technology solutions and services for veterinary practices, and part of Cencora (formerly AmerisourceBergen), today announced that Shepherd Veterinary Software, which offers a veterinary practice information management software (PIMS), is now fully and seamlessly integrated with MWI’s AllyDVM client engagement platform .

Key Points: 
  • MWI Animal Health, a provider of state-of-the-art technology solutions and services for veterinary practices, and part of Cencora (formerly AmerisourceBergen), today announced that Shepherd Veterinary Software, which offers a veterinary practice information management software (PIMS), is now fully and seamlessly integrated with MWI’s AllyDVM client engagement platform .
  • AllyDVM's integration with Shepherd, the nation’s fastest-growing cloud-based PIMS, is a significant step forward in MWI Animal Health’s commitment to ensuring veterinary practices have continuous access to the platforms that underpin their day-to-day operations.
  • “At Shepherd, we integrate with veterinary solutions that truly benefit our users,” said Shepherd’s VP of Growth, Conor Guptill.
  • With this integration, practices can operate more smoothly, their clients feel more connected to the practice and the veterinary team can easily manage their operations with Shepherd’s user-friendly PIMS.”
    “This agreement with Shepherd further shows our dedication to today’s veterinary practices,” said Courtney Carter, Vice President and Head of AllyDVM, MWI Animal Health.